Gleneagles Hong Kong Hospital opens today
Bringing best-in-class healthcare services and patient experience to Hong Kong people
Dr Tan See Leng, Group Chief Executive Officer and Managing Director of Parkway Pantai (middle), Mr Tsang Yam Pui, Chief Executive Officer of NWS Holdings Limited (second right), Dr Kelvin Loh, interim Chief Executive Officer of GHK (second left), Mr Lee Cheow Seng, Deputy Chief Executive Officer of GHK (far right), and Dr Alexander Chiu, Chief Operating Officer of GHK (far left)
(21 March 2017 – Hong Kong) Gleneagles Hong Kong Hospital (GHK), a 500-bed multi-specialty private tertiary hospital located in Wong Chuk Hang on Hong Kong Island South, goes into operation today to serve Hong Kong people with best-in-class healthcare services and patient experience. GHK is a joint venture between Parkway Pantai and NWS Holdings Limited, with Li Ka Shing Faculty of Medicine of The University of Hong Kong (HKU) as its exclusive clinical partner.
Comprehensive range of services
GHK provides a wide range of clinical services spanning more than 35 specialties and subspecialties. In addition to inpatient services, GHK’s specialist outpatient services span 16 specialties through 14 clinics, including General Surgery, General Medicine, Orthopaedic Surgery, ENT /Eye, Urology, Paediatric, Chinese Medicine and Health Screening etc. Other service centres include Endoscopy Centre, Rehabilitation Centre, Cardiovascular Laboratory, Chemotherapy Centre and Dialysis Centre. GHK also provides Accident and Emergency services (A&E) which are provided by A&E specialists and medical professionals trained to provide prompt and appropriate treatments to patients with urgent medical conditions.
State-of-the-art medical equipment and facilities
As a brand-new hospital, GHK has the advantage of being one of the most modern and well-equipped hospitals in Hong Kong, providing state-of-the-art equipment and facilities including PET CT, nuclear medicine facilities, 24-hour fully-automated core laboratory system, Critical Care Unit and operating theatres capable of conducting complex surgeries. GHK is one of the first private hospitals in Hong Kong to use the fully-automated track system that handles routine blood tests and chemistry tests. It is also one of the first private hospitals in Hong Kong to use the automated, decentralised medication dispensing system that ensures efficient and accurate drug management and dispensing. Other advanced equipment in the pipeline include the Linear Accelerator and Radiosurgery and PET MRI.
Dr Tan See Leng, Group Chief Executive Officer and Managing Director of Parkway Pantai, says, “The opening of Gleneagles Hong Kong Hospital is an important milestone of the Group as it marks our first tertiary healthcare facility in Hong Kong. In addition to delivering excellent clinical outcomes, we believe that giving our patients peace of mind through a transparent fee structure will position GHK as a unique patient-centric hospital. Drawing on the expertise of Parkway Pantai, NWS Holdings and Li Ka Shing Faculty of Medicine of The University of Hong Kong, we are committed to offering best-in-class healthcare services and patient care to the people of Hong Kong.”
Mr Tsang Yam Pui, Chief Executive Officer of NWS Holdings Limited, says, “Completing a project of this scale, starting from construction to bringing it to operational level in three years’ time, is a demonstration of professionalism, expertise and teamwork of the GHK team. Gleneagles Hong Kong Hospital is a hospital for Hong Kong people with 70% of the bed days being set aside for Hong Kong residents. We also take pride in being a private teaching hospital to train doctors, nurses and allied healthcare professionals, contributing to the development of Hong Kong’s healthcare industry and advancement of clinical research.”
Professor Gabriel Leung, Dean of Medicine, HKU, says, "As a new member of HKU Health System, GHK is our first full-scale private sector experiment in partnership with a global health care conglomerate. We shall make use of our expertise to apply standardization of best clinical governance practice in GHK. With the engagement in direct service provision at GHK, we could expand our patient base thereby providing opportunities for high quality clinical research in a wider spectrum of diseases and clinical conditions."
All-inclusive and fixed-price medical packages
GHK is the first private hospital in Hong Kong to provide at least 51% of inpatient bed days at packaged rates. At the initial stage, 54 medical packages will be provided. All packages are fixed-price and all-inclusive in nature, covering complications required, including re-operation and ICU care, within the prescribed length of stay. Fee advisory services will be offered to all patients before admission to help patients better manage costs and make informed decisions.
High patient comfort and privacy with warm and healing ambience
GHK places great emphasis on patients’ comfort and privacy. It offers a selection of inpatient room types, ranging from its 2-bedded standard rooms to single rooms and suites, to meet different patients’ needs and preferences. This is complemented by thoughtful interior designs that create a warm, healing ambience throughout the hospital.
Comprising two towers with nine levels, the design and layout of GHK facilitates efficient operation and patient flows with clear zoning of key services. Landscape gardens are located on the Third floor and Fifth floor, providing patients with a peaceful, green, outdoor environment during their stay. These gardens, together with a footbridge on the Sixth Floor, connect the two towers.
Gleneagles Hong Kong Hospital
Located at Wong Chuk Hang on Hong Kong Island South, Gleneagles Hong Kong Hospital (GHK) provides 500 beds, cutting-edge medical technologies and a comprehensive range of clinical services spanning more than 35 specialties and subspecialties. As Hong Kong’s top-notch private teaching hospital, GHK will also contribute to the training and development of healthcare professionals and advancement of clinical research.
GHK is a partnership between Parkway Pantai and NWS Holdings with the participation of Li Ka Shing Faculty of Medicine of The University of Hong Kong as the exclusive clinical partner.
Parkway Pantai Limited
Parkway Pantai is one of Asia’s largest integrated private healthcare groups operating in Singapore, Malaysia, India, China, Brunei and United Arab Emirates. For over 40 years, its Mount Elizabeth, Gleneagles, Pantai and Parkway brands have established themselves as the region’s best known brands in private healthcare, synonymous with best-in-class patient experience and outcomes.
Leveraging its global track record for medical excellence and managing world-class hospitals, Parkway Pantai is committed to making a difference in people’s lives through excellent patient care, steadily expanding its reach in markets where demand for quality care is strong and growing.
Parkway Pantai is a leading healthcare player in its home markets of Singapore, Malaysia and India and key growth markets of China and Hong Kong. It is part of IHH Healthcare, the world’s second largest healthcare group by market capitalisation. IHH operates more than 10,000 licensed beds across 52 hospitals in 10 countries worldwide, offering the full spectrum of integrated healthcare services from clinics to hospitals to quaternary care and a wide range of ancillary services including medical education.
NWS Holdings Limited
NWS Holdings Limited ("NWS Holdings", Hong Kong stock code: 659) is the infrastructure and service flagship of New World Development Company Limited (Hong Kong stock code: 17). It has diverse businesses and investments predominantly in Hong Kong and Mainland China, comprising toll roads, environmental management, port and logistics facilities, rail container terminals, commercial aircraft leasing, facilities management, healthcare services, construction and public transport. Please visit www.nws.com.hk for details.
Li Ka Shing Faculty of Medicine of The University of Hong Kong
The Medical Faculty of The University of Hong Kong (HKU) is the longest established institution in higher education of Hong Kong. It was founded as the Hong Kong College of Medicine in 1887 and was renamed as the Hong Kong College of Medicine in 1907. The Faculty was deemed as the premier Faculty when the University was established in 1911. From its modest beginning, the Faculty has now become the largest faculty of the University, with over 400 full-time academic and academic-related staff and 800 research and research-related support personnel. The undergraduate student population is about 2,900 and the postgraduate student population is about 1,500. The Faculty is comprised of 14 departments, School of Biomedical Sciences, School of Chinese Medicine, School of Nursing, School of Public Health and a number of research centres focusing on various strengths of research.